Jonathan Summers, CEO, acquired 11,270,855 Common Shares on a direct ownership basis at a price of $0.200 through a prospectus or prospectus exempt offering on July 24th, 2020. This represents a $2,254,171 investment into the company's shares and an account share holdings change of greater than 100%.
EXMCeuticals is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Exmceuticals Inc. is a Canada-based cannabis company. The Company is focused on cultivation of cannabis and hemp, and the production of pharmaceutical grade, psychotropic and non-psychotropic cannabis and hemp ingredients for the pharmaceutical, therapeutical and nutraceutical industries. The Company, through its subsidiary holds the rights to a cannabis license in the Kuba Kingdom, Mweka, Kasai Province, Democratic Republic of Congo, and the rights to a land concession for the cultivation of cannabis and hemp, and processing and export of high-grade pharmaceutical cannabinoid ingredients.
No Comments